Gossamer Bio
GOSS
123 hedge funds and large institutions have $689M invested in Gossamer Bio in 2020 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 49 increasing their positions, 28 reducing their positions, and 8 closing their positions.
175% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 8
120% more capital inflows, than outflows
Capital inflows: $73.8M | Capital outflows: $33.5M
104% more call options, than puts
Call options by funds: $5.67M | Put options by funds: $2.79M
75% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 28
13% more funds holding
Funds holding: 109 → 123 (+14)
3.96% more ownership
Funds ownership: 69.28% → 73.24% (+4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Palo Alto Investors
Palo Alto,
California
|
+$11.6M |
| 2 |
Marshall Wace North America
New York
|
+$11.1M |
| 3 |
Goldman Sachs
New York
|
+$8.46M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$5.09M |
| 5 |
Nuveen
Charlotte,
North Carolina
|
+$5.04M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$6.82M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$4.26M |
| 3 |
AG
Artal Group
Luxembourg
|
-$3.98M |
| 4 |
Morgan Stanley
New York
|
-$2.39M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.28M |
GOSS Hedge Fund Activity: Q3 2020 in Review
123 of the 4,972 institutional investors tracked by Wall St. Rank reported a position in Gossamer Bio (GOSS) for Q3 2020, worth a combined $689M — up 0.79% from $684M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new GOSS positions and 8 closed out — a net gain of 14 holders — while 49 added to existing stakes and 28 trimmed.
The largest buyer was Palo Alto Investors, adding an estimated $11.6M. The largest seller was Capital International Investors, cutting an estimated $6.82M.
- 123 institutional investors held Gossamer Bio (GOSS) as of Q3 2020, up from 109 in Q2 2020.
- Funds reported $689M of Gossamer Bio stock for Q3 2020, up 0.79% quarter-over-quarter.
- 22 funds opened new Gossamer Bio positions in Q3 2020 and 8 closed out, a net change of +14 holders.
- The largest Gossamer Bio buyer in Q3 2020 was Palo Alto Investors, an estimated $11.6M added.
- The largest Gossamer Bio seller in Q3 2020 was Capital International Investors, an estimated $6.82M sold.
Based on aggregated 13F filings for Q3 2020.